HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug iptacopan offers hope for rare transplant complication
Disease control Not yet recruitingThis study tests a pill called iptacopan for people who develop a serious blood vessel condition (TA-TMA) after a stem cell transplant. The drug aims to block harmful immune activity and improve survival. About 30 participants will take the pill and be monitored for up to 2 years…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 26, 2026 07:59 UTC
-
Prehab before transplant: study tests exercise to boost recovery
Disease control Not yet recruitingThis study tests whether a personalized exercise and education program before a stem cell transplant can help patients feel stronger and recover faster. 68 adults preparing for transplant will either join the program or receive standard care. The program includes supervised exerc…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: NA • Sponsor: Hospital del Salvador • Aim: Disease control
Last updated May 26, 2026 07:25 UTC